alexa In Vitro COX Inhibitory Activity Of Novel α-aminoarylpropionic Acid Derivatives
ISSN: 2161-0444

Medicinal chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

3rd International Conference on Medicinal Chemistry & Computer Aided Drug Designing
December 08-10, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

A G Zhamharyan, M G Balasanyan, L G Zhamharyan, A S Sagian and H V Topchyan
ScientificTracks Abstracts: Med Chem
DOI: 10.4172/2161-0444.S1.011
The structure activity relationship of NSAIDs evidences that arylpropionic acid derivatives - one of the wide used group for treatment of inflammation diseases, possess cycloxygenase inhibiting activity. In view of this, in previous investigations it was synthesized the new derivatives of α-aminoarylpropionic acid and assessed their pharmacological activity. Obtained results demonstrated in vivo anti-inflammatory and anti-nociceptive activities of novel synthesized α-aminoarylpropionic acid derivatives. In presented work it was studied in vitro COX-1 and COX-2 inhibitory activity of mentioned compounds. The COX inhibitory activity was measured using COX Inhibitor Screening Assay Kit, according to the protocol. Experimental data evident that testified compounds possess both human recombinant COX-1 and COX-2 non selective inhibitor activity (IC 50˂10 μM), with different affinity to COX isoforms. The phenyl-alanine derivative appear comparable more activity to COX1 (IC 50=1.9 μM). The S-triazole derivative shows a highest inhibitor activity with more selectivity to COX 2 (IC 50=0.9 μM). Thus, the study suggests that triazoles derivatives of α-aminoarylpropionic acid could be used as a starting point for the development of novel COX inhibitors.
A G Zhamharyan has completed her PhD at the age of 29 years from Yerevan State Medical University and now preparing postdoctoral studies from the same university. She is the head of Department of Pharmacy in Yerevan State Medical University. She has published more than 25 papers in reputed journals connecting to study of the natural and chemical compound anti-inflammatory and anti-nociceptive activities.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version